Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them.
OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life.
Company Details
- Employees
- 17
- Founded
- -
- Address
- London, Sw7, Gb
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://osstec.uk
- HQ
- London
Osstec Questions
Osstec's website is http://osstec.uk
Osstec's LinkedIn profile is https://uk.linkedin.com/company/osstec
Osstec has
17 employees.
View email and phone details for 17
employees at Osstec.
Osstec's industry is
Medical Equipment Manufacturing
Osstec's top competitors are
Matoha,
Kaikaku,
Signatur Biosciences,
Reactwise,
Pulpatronics,
Henleyprint3d,
Orbio Earth (Yc S23),
Smart Surgical Solutions,
Peachies,
Winvest Collective.
Osstec's categories are Medical Equipment Manufacturing
Osstec's founding year is 2021
